Literature DB >> 23608402

Menstrual blood derived mesenchymal cells ameliorate cardiac fibrosis via inhibition of endothelial to mesenchymal transition in myocardial infarction.

Zhaocai Zhang1, Jian-An Wang, Yinchuan Xu, Zhi Jiang, Rongrong Wu, Lihan Wang, Panpan Chen, Xinyang Hu, Hong Yu.   

Abstract

Entities:  

Keywords:  Cardiac fibroblast; Endothelial to mesenchymal transition; Menstrual blood; Mesenchymal stem cell; Myocardial infarction

Mesh：

Year:  2013        PMID： 23608402     DOI： 10.1016/j.ijcard.2013.03.126

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  19 in total

Review 1.  Therapeutic potential of menstrual blood-derived endometrial stem cells in cardiac diseases.

Authors:  Yanli Liu; Rongcheng Niu; Wenzhong Li; Juntang Lin; Christof Stamm; Gustav Steinhoff; Nan Ma
Journal:  Cell Mol Life Sci       Date:  2019-02-05       Impact factor: 9.261

2.  Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition.

Authors:  Junyi Huang; Wenju Lu; Haiping Ouyang; Yuqin Chen; Chenting Zhang; Xiaoyun Luo; Meichan Li; Jiaze Shu; Qiuyu Zheng; Haixia Chen; Jiyuan Chen; Haiyang Tang; Dejun Sun; Jason X-J Yuan; Kai Yang; Jian Wang
Journal:  Am J Respir Cell Mol Biol       Date:  2020-01       Impact factor: 6.914

3.  IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection.

Authors:  Hong Qin; Chenglu Sun; Yanglin Zhu; Yafei Qin; Shaohua Ren; Zhaobo Wang; Chuan Li; Xiang Li; Baoren Zhang; Jingpeng Hao; Guangming Li; Hongda Wang; Bo Shao; Jingyi Zhang; Hao Wang
Journal:  Stem Cell Res Ther       Date:  2022-07-15       Impact factor: 8.079

Review 4.  Customizable biomaterials as tools for advanced anti-angiogenic drug discovery.

Authors:  Eric H Nguyen; William L Murphy
Journal:  Biomaterials       Date:  2018-07-26       Impact factor: 12.479

5.  Hypoxia preconditioned mesenchymal stem cells prevent cardiac fibroblast activation and collagen production via leptin.

Authors:  Panpan Chen; Rongrong Wu; Wei Zhu; Zhi Jiang; Yinchuan Xu; Han Chen; Zhaocai Zhang; Huiqiang Chen; Ling Zhang; Hong Yu; Jian'an Wang; Xinyang Hu
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

6.  Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure.

Authors:  Lu Chen; Bingyu Xiang; Xiaojun Wang; Charlie Xiang
Journal:  Stem Cell Res Ther       Date:  2017-01-23       Impact factor: 6.832

7.  Transplantation of Menstrual Blood-Derived Mesenchymal Stem Cells Promotes the Repair of LPS-Induced Acute Lung Injury.

Authors:  Bingyu Xiang; Lu Chen; Xiaojun Wang; Yongjia Zhao; Yanling Wang; Charlie Xiang
Journal:  Int J Mol Sci       Date:  2017-03-27       Impact factor: 5.923

8.  Human Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators.

Authors:  Lijun Chen; Chunfeng Zhang; Lu Chen; Xiaojun Wang; Bingyu Xiang; Xiaoxing Wu; Yang Guo; Xiaozhou Mou; Li Yuan; Bo Chen; Jinfu Wang; Charlie Xiang
Journal:  Stem Cells Transl Med       Date:  2016-07-28       Impact factor: 6.940

9.  Enhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21.

Authors:  Kan Wang; Zhi Jiang; Keith A Webster; Jinghai Chen; Hengxun Hu; Yu Zhou; Jing Zhao; Lihan Wang; Yingchao Wang; Zhiwei Zhong; Cheng Ni; Qingju Li; Charlie Xiang; Ling Zhang; Rongrong Wu; Wei Zhu; Hong Yu; Xinyang Hu; Jian'an Wang
Journal:  Stem Cells Transl Med       Date:  2016-08-29       Impact factor: 6.940

10.  Transplantation of Human Menstrual Blood-Derived Mesenchymal Stem Cells Alleviates Alzheimer's Disease-Like Pathology in APP/PS1 Transgenic Mice.

Authors:  Yongjia Zhao; Xin Chen; Yichen Wu; Yanling Wang; Yifei Li; Charlie Xiang
Journal:  Front Mol Neurosci       Date:  2018-04-24       Impact factor: 5.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.